Clinical trial
Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations
NCT02026999 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations
- Lead sponsor
- Ankara University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- February 28, 2013
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nasal septum deviation